BG107471A - Indole derivatives useful for the treatment of cns disorders - Google Patents

Indole derivatives useful for the treatment of cns disorders

Info

Publication number
BG107471A
BG107471A BG107471A BG10747103A BG107471A BG 107471 A BG107471 A BG 107471A BG 107471 A BG107471 A BG 107471A BG 10747103 A BG10747103 A BG 10747103A BG 107471 A BG107471 A BG 107471A
Authority
BG
Bulgaria
Prior art keywords
treatment
cns disorders
indole derivatives
derivatives useful
disorders
Prior art date
Application number
BG107471A
Other languages
Bulgarian (bg)
English (en)
Inventor
Benny Bang-Andersen
Jakob Felding
Jan Kehler
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of BG107471A publication Critical patent/BG107471A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG107471A 2000-06-29 2003-01-17 Indole derivatives useful for the treatment of cns disorders BG107471A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001018 2000-06-29
PCT/DK2001/000407 WO2002000645A1 (en) 2000-06-29 2001-06-13 Indole derivatives useful for the treatment of cns disorders

Publications (1)

Publication Number Publication Date
BG107471A true BG107471A (en) 2003-10-31

Family

ID=8159589

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107471A BG107471A (en) 2000-06-29 2003-01-17 Indole derivatives useful for the treatment of cns disorders

Country Status (23)

Country Link
US (1) US20030232822A1 (xx)
EP (1) EP1299380B1 (xx)
JP (1) JP2004501912A (xx)
KR (1) KR20030011365A (xx)
CN (1) CN1439004A (xx)
AR (1) AR028736A1 (xx)
AT (1) ATE268765T1 (xx)
AU (1) AU2001273882A1 (xx)
BG (1) BG107471A (xx)
BR (1) BR0112286A (xx)
CA (1) CA2414115A1 (xx)
CZ (1) CZ20024192A3 (xx)
DE (1) DE60103761D1 (xx)
EA (1) EA200300084A1 (xx)
HU (1) HUP0300786A2 (xx)
IL (1) IL153254A0 (xx)
IS (1) IS6642A (xx)
MX (1) MXPA02012506A (xx)
NO (1) NO20026029D0 (xx)
PL (1) PL358966A1 (xx)
SK (1) SK1092003A3 (xx)
WO (1) WO2002000645A1 (xx)
ZA (1) ZA200209886B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
WO2004020437A1 (en) * 2002-08-29 2004-03-11 H. Lundbeck A/S S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
DE102004027358A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
CN101522197B (zh) * 2006-07-31 2013-12-11 詹森药业有限公司 尾加压素ⅱ受体拮抗剂
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider
FR2953839A1 (fr) * 2009-12-14 2011-06-17 Sanofi Aventis Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994020497A1 (en) * 1993-03-01 1994-09-15 Merck Sharp & Dohme Limited Pyrrolo-pyridine derivatives
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
CN1439004A (zh) 2003-08-27
JP2004501912A (ja) 2004-01-22
NO20026029L (no) 2002-12-16
KR20030011365A (ko) 2003-02-07
DE60103761D1 (de) 2004-07-15
AR028736A1 (es) 2003-05-21
CZ20024192A3 (cs) 2003-04-16
EP1299380B1 (en) 2004-06-09
US20030232822A1 (en) 2003-12-18
EP1299380A1 (en) 2003-04-09
PL358966A1 (en) 2004-08-23
CA2414115A1 (en) 2002-01-03
WO2002000645A1 (en) 2002-01-03
IS6642A (is) 2002-11-29
HUP0300786A2 (hu) 2003-07-28
SK1092003A3 (en) 2003-05-02
BR0112286A (pt) 2003-05-13
AU2001273882A1 (en) 2002-01-08
MXPA02012506A (es) 2003-04-25
ZA200209886B (en) 2003-12-05
ATE268765T1 (de) 2004-06-15
EA200300084A1 (ru) 2003-06-26
NO20026029D0 (no) 2002-12-16
IL153254A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
MY122531A (en) N-(indolecarbonyl) piperazine derivatives
ATE433962T1 (de) Piperazinylpyrazinverbindungen als antagonisten des serotonin-5-ht2-rezeptors
GB0325956D0 (en) Novel compounds
MXPA06000716A (es) Derivados de quinolina y quinazolina que tienen afinidad hacia receptores del tipo 5ht1.
MXPA06001647A (es) 6-(2, 2, 2-trifluoroetilamino) -7-cloro-2, 3, 4, 5-tetrahidro- 1h-benzo[d] azepina como un agonista del receptor 5-ht2c.
TW200503713A (en) Novel compounds
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
BG106961A (en) Phenylpiperazinyl derivatives
CA2411412A1 (en) Indole derivatives useful for the treatment of cns disorders
MXPA05010646A (es) Pirazoles sustituidos.
ATE495183T1 (de) Ruthenium-diphosphin komplexe und ihre verwendung als katalysatoren
SI1893589T1 (sl) Substituirani N-benzo(d)izoksazol-3-il-aminski derivati kot inhibitorji mGluR5, serotonin-(5-HT) in noradrenalinskih receptorjev in njihova uporaba za pripravo zdravil
EA200600860A1 (ru) Производные n-тиазол-2-илбензамида
DK1636239T3 (da) Indolderivater med en forbedret antipsykotisk aktivitet
BG107471A (en) Indole derivatives useful for the treatment of cns disorders
BG105710A (en) 5ht1 antagonists for antidepressant therapy
MXPA04000358A (es) Hexahidroazepino (4,5-g) indoles e indolinas como ligandos del receptor 5-ht.
ATE256678T1 (de) 4-(2-pyridyl)piperazine als agonisten des 5ht7 rezeptors
MY123686A (en) Indole derivatives and their use as 5ht2a ligands
CA2416212A1 (en) Indole derivatives useful for the treatment of cns disorders
BG107450A (en) Indole derivatives useful for the treatment of cns disorders
MY139258A (en) Carbamoyl-type benzofuran derivatives
BR0111764A (pt) Derivados de indol úteis para o tratamento de distúrbios do sistema nervoso central (snc); composto; composição farmacêutica; utilização de composto e método de tratamento
HUP0301748A2 (hu) A központi idegrendszer megbetegedésének kezelésére alkalmas indolszármazékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
WO2000012500A3 (en) 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands